1. What data in particular will be shared?
   Response - All of the individual participant data collected during the trial, after de-identification.
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   
   
3. Who will be able to view these files?
   Response - Researchers who provide a methodologically sound proposal.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [beminaja@gmail.com].
   


6. For how long will this data be available start date provided 03-05-2021 and end date provided 09-03-2021?
   Response - Immediately following publication. No end date.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

This study is a randomized control trail, parallel group evaluating the effectiveness of MCBT on Premenstrual symptoms ,Depression, Blood Pressure, Blood Glucose level, work and social adjustment among women’s working in selected organizations at Kalaburagi .The primary outcome measures assessment of PMS and Depression will be done by using the following at 0,2 month,4 month and 6 month.

Premenstrual Symptom Scale. (PMSS) It  is comprised of 40 questions with three subscales (physiological, psychological and behavioral symptoms) ,it is a five point Likert type scale varying from no symptoms  to  very severe. This scale consists of forty items are measured according to the following scoring system. Each item is scored from 0-5. PMSS has a validity of 0.81 and a reliability of 0.97.      

Hamilton Depression Rating Scale The total Hamilton Depression (HAM-D) Rating Scale provides and indication of depression and, over time, provides a valuable guide to progress. It has a good reliability 0.83 and excellent internal consistency cronbachs alpha 0.92 In general the higher the total score the more sever the depression. HAM-D score level of depression:10 - 13 mild; 14-17 mild to moderate; >17 moderate to severe.

The secondary outcomes are assessed using the below tools at 0, 2 month,4 month and 6 month

Blood pressure assessment will be done by using  a Sphygmomanometer. Reliability of the instrument will be calculated by test retest method. Checklist will be prepared for recording the blood pressure.

Systolic blood pressure Normal  100 to140 mm of Hg ,Mild hypertension 141 to 160 mm of Hg,Moderate Hypertension 161 to 180 mm of Hg,Severe Hypertension 181 to 210 mm of Hg

Diastolic blood pressure Normal 60 to 90 mm of Hg,Mild Hypertension 91 to 100 mm of Hg,Moderate Hypertension 101 to 110 of Hg,Severe Hypertension 111 to120 mm of Hg

 Blood glucose level only FBS will be assessed by using glucometer. Reliability of the instrument will be calculated by test retest method. Checklist will be prepared for recording the glucose level in the blood.

Fasting Blood Sugar Normal  90 - 120 mg/dl ,Medium 121 -160 mg/dl,High 161- 240mg/dl ,Too high 241 - 300 mg/dl Very High  above 301mg 

 Work and Social Adjustment Scale (WSAS) is a simple and reliable measure for impairment in functioning. In this study it assesses the impact of a woman, mental health difficulties on their ability to function in terms of work, home management, social leisure, private leisure and personal or family relationships. This instrument has 5 items ,internal scale consistency ranged from 0.70 to 0.94.

Scoring 0-9  No impairment to Low impairment,10-19 Moderate impairment,20-40 severe impairment.